Article
Predicted IL-18/IL-18R Binding Improvement Through Protein Interface Modification with Computer-Aided Design.
Biomolecules - 25 Sept 2025
Prompat Napat, Peeyatu Chariya, Saetang Jirakrit, Roongsawang Niran, Sangkhathat Surasak, Tipmanee Varomyalin
Abstract excerpt
Cytokine-mediated immunotherapy has rapidly emerged as an effective alternative approach for cancer treatment by modulating the anti-tumor response. Interleukin-18 (IL-18) is considered as a promising cancer therapeutic agent due to the ability of cytokines to inhibit cancer by enhancing natural killer (NK) cell and cytotoxic T cell responses. Since the activity of IL-18 is required for the specific binding to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
